Amphastar Pharmaceuticals
AMPH
AMPH
108 hedge funds and large institutions have $397M invested in Amphastar Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
108
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.15M | |
| 2 | +$3.79M | |
| 3 | +$2.7M | |
| 4 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$2.03M |
| 5 |
Renaissance Technologies
New York
|
+$1.83M |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$1.99M | |
| 3 | -$1.51M | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$1.24M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$934K |